These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Clinical efficacy of colesevelam in type 2 diabetes mellitus. Brunetti L; Campbell RK J Pharm Pract; 2011 Aug; 24(4):417-25. PubMed ID: 21813819 [TBL] [Abstract][Full Text] [Related]
25. Colesevelam hydrochloride: usefulness of a specifically engineered bile acid sequestrant for lowering LDL-cholesterol. Corsini A; Windler E; Farnier M Eur J Cardiovasc Prev Rehabil; 2009 Feb; 16(1):1-9. PubMed ID: 19237992 [TBL] [Abstract][Full Text] [Related]
26. Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United States. Fox KM; Gandhi SK; Ohsfeldt RL; Blasetto JW; Bays HE Curr Med Res Opin; 2007 Sep; 23(9):2125-33. PubMed ID: 17655813 [TBL] [Abstract][Full Text] [Related]
27. Effect of colesevelam hydrochloride on glycemia and insulin sensitivity in men with the metabolic syndrome. Vega GL; Dunn FL; Grundy SM Am J Cardiol; 2011 Oct; 108(8):1129-35. PubMed ID: 21813109 [TBL] [Abstract][Full Text] [Related]
28. [Hypercholesterolemia: when statins are not enough or not tolerated. With combination therapy to LDL cholesterol target goal]. MMW Fortschr Med; 2012 Jul; 154(13):86-7. PubMed ID: 22957390 [No Abstract] [Full Text] [Related]
29. Hypercholesterolemia treatment patterns and low-density lipoprotein cholesterol monitoring in patients with a diagnosis of atherosclerosis in clinical practice. Davidson MH; Gandhi SK; Ohsfeldt RL; Fox KM Am J Med; 2009 Jan; 122(1 Suppl):S51-9. PubMed ID: 19110088 [TBL] [Abstract][Full Text] [Related]
31. Rationale and design of a clinical trial to evaluate metformin and colesevelam HCl as first-line therapy in type 2 diabetes and colesevelam HCl in prediabetes. Jones MR; Mudaliar S; Hernandez-Triana E; Unnikrishnan AG; Lai YL; Abby SL; Misir S; Jin X; Nagendran S Curr Med Res Opin; 2009 Sep; 25(9):2239-49. PubMed ID: 19622007 [TBL] [Abstract][Full Text] [Related]
32. Colesevelam HCl improves fasting plasma glucose and lipid levels in patients with prediabetes. Handelsman Y; Abby SL; Jin X; Donovan JM; Jones MR Postgrad Med; 2009 Nov; 121(6):62-9. PubMed ID: 19940418 [TBL] [Abstract][Full Text] [Related]
33. Titration patterns with rosuvastatin as compared with other statins in clinical practice: a retrospective observational cohort study using an electronic medical record database. Fox KM; Gandhi SK; Ohsfeldt RL; Blasetto JW; Davidson MH Clin Ther; 2007 Nov; 29(11):2385-94. PubMed ID: 18158079 [TBL] [Abstract][Full Text] [Related]
34. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance. Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465 [TBL] [Abstract][Full Text] [Related]
35. Colesevelam - a bile acid sequestrant for treating hypercholesterolemia and improving hyperglycemia. Esan O; Viljoen A; Wierzbicki AS Expert Opin Pharmacother; 2022 Aug; 23(12):1363-1370. PubMed ID: 35968655 [TBL] [Abstract][Full Text] [Related]
36. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study. Alvarez-Sala LA; Cachofeiro V; Masana L; Suarez C; Pinilla B; Plana N; Trias F; Moreno MA; Gambus G; Lahera V; Pintó X Clin Ther; 2008 Jan; 30(1):84-97. PubMed ID: 18343245 [TBL] [Abstract][Full Text] [Related]
37. Efficacy of colesevelam on lowering glycemia and lipids. Aggarwal S; Loomba RS; Arora RR J Cardiovasc Pharmacol; 2012 Feb; 59(2):198-205. PubMed ID: 21983746 [TBL] [Abstract][Full Text] [Related]
38. Lipid-modifying therapy and attainment of cholesterol goals in Europe: the Return on Expenditure Achieved for Lipid Therapy (REALITY) study. Van Ganse E; Laforest L; Alemao E; Davies G; Gutkin S; Yin D Curr Med Res Opin; 2005 Sep; 21(9):1389-99. PubMed ID: 16197657 [TBL] [Abstract][Full Text] [Related]
39. [Screening for hyperlipidemia in cardiovascular high-risk patients in austrian diabetes ambulances]. Brath H; Wascher TC; Kästenbauer T; Toplak H MMW Fortschr Med; 2012 Jun; 154 Suppl 2():41-7. PubMed ID: 23424754 [TBL] [Abstract][Full Text] [Related]
40. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin. Stein E; Stender S; Mata P; Sager P; Ponsonnet D; Melani L; Lipka L; Suresh R; Maccubbin D; Veltri E; Am Heart J; 2004 Sep; 148(3):447-55. PubMed ID: 15389231 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]